Nilotinib in Cognitively Impaired Parkins... - Cure Parkinson's

Cure Parkinson's

26,569 members27,876 posts

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 Clinical Trial Accepting Now

p-oui profile image
13 Replies

foxtrialfinder.michaeljfox....

Open Label Dose Escalation of Nilotinib in Cognitively Impaired Parkinson Disease Patients With Elevated Cerebrospinal Fluid and Blood α-Synuclein

Contact:

MedStar Georgetown University Hospital, Washington, DC

Connell Owings

rco24@georgetown.edu

202-444-2658

Written by
p-oui profile image
p-oui
To view profiles and participate in discussions please or .
Read more about...
13 Replies
jeffreyn profile image
jeffreyn

p-oui,

I've had a look at the webpage you linked to. It says that the status of this trial is "completed".

Jeff

Isthistheone profile image
Isthistheone in reply tojeffreyn

Gotta be the one DRs Moussa and Pagan completed and reported on in 2015. That was open label, no placebo. Too bad Georgetown and MJFF are feuding. Nilotinib, brand name Tasigna manufactured by Novartis, demonstrated very positive results. Extremely unfortunate that PWP have to suffer for 5+ years for FDA approval. As most are aware, Tasigna is already FDA approved for a specific type of leukemia. Any licensed physician can therefore legally prescribe it "off label" for PD.

In my opinion, bureaucratic red tape, the pharmaceutical industry, and parts of the medical establishment are keeping Tasigna away from sufferers of PD. Tasigna costs for leukemia patients are $13,000 per month. Nothing more needs to be said.

p-oui profile image
p-oui in reply toIsthistheone

It is more than sad, it is a travesty and the cost is lives - I don't know how else to say it. It seems we could speed from 5 years to 1 since it is FDA approved at least but I know that's not possible.

Hikoi profile image
Hikoi

A double-blind, placebo-controlled clinical study of Nilotinib (Tasigna®) in patients with Parkinson's disease

adisinsight.springer.com/tr...

p-oui profile image
p-oui in reply toHikoi

Hikoi thank you! This is great news!

Isthistheone profile image
Isthistheone in reply toHikoi

This is very good news. Nothing yet on the calendar at AMC in Albany NY. I hope this has wings and flies really soon. Read up, this drug has more than just promise. Data shows it works!

CPT_Helen profile image
CPT_HelenPartner

This trial is also not recruiting yet.

Many thanks

Helen

p-oui profile image
p-oui in reply toCPT_Helen

Yes it is coming in a few months which is very good news

rhenry45 profile image
rhenry45

I have 100 grams of the powder form of nilotnib but I am scared to take it due to potential side effects.

p-oui profile image
p-oui

Henry, I don't blame you. I would want to do this under a doctors supervision.

Mamapaula profile image
Mamapaula

Please take me 79 no health problems I can bring camper and live there for trial. I'm in sc and go to MUSC muffin program. I'm not giving up. Please help our family. The Tasigna is $40 a pill from Canada. pjsartain@bellsouth.net

Scorpgirl profile image
Scorpgirl

Georgetown University is actively enrolling patients in the phase 2 trial of nilotinib right now! Great news for the PD community!!!!

munchybunch profile image
munchybunch

can you buy Tasigna in Canada ?

Not what you're looking for?

You may also like...

n-acetyl cysteine (NAC) parkinsons clinical trial accepting now

Here is some info on recent study conducted on NAC and it showed what looks like strong results:...
p-oui profile image

Stemregen in clinical trial

There is a clinical trial in Spain researching the efficace of Stemregen natural caps in PD....
michelagvolpe profile image

Face spasm in parkinson disease

Hi, my mother gets sever face and nose spasm that bothers her a lot and cant swallow or chew well....
Rasa2006 profile image

Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial

Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or...
Kia17 profile image

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020

145 trials are registered and ongoing clinical trials for therapeutics targeting PD, of which 51...
Farooqji profile image